09/21/23 6:00 AMNasdaq : ICLR earningsICON plc Schedules Third Quarter 2023 Earnings Conference CallICON plc, a world-leading healthcare intelligence and clinical research organization, today announced that it will release its financial results for the third quarter 2023 after the market closes on Wednesday, October 25, 2023. The company will hold a conference call and webcast to discuss its financial results and performance on Thursday, October 26, 2023...RHEA-AIneutral
09/20/23 7:15 AMNasdaq : ICLR clinical trialICON Releases Expanded End-to-end Clinical Trial Tokenisation SolutionICON plc, a world-leading healthcare intelligence and clinical research organisation, today announces the release of its next generation Clinical Trial Tokenisation solution. The combination of ICON’ s proprietary tokenisation engine, access to real-world data and advanced clinical analytics expertise, now delivered through a cohesive and seamless...RHEA-AIpositive
09/13/23 7:15 AMNasdaq : ICLR partnershipclinical trialcovid-19BARDA Partners With ICON to Execute Next Generation COVID-19 Vaccines Clinical TrialICON plc, a world-leading healthcare intelligence and clinical research organisation, today announces that it is partnering with the U.S. Biomedical Advanced Research and Development Authority, part of the Administration for Strategic Preparedness and Response within the U.S. Department of Health and Human Services, to execute a clinical trial to...RHEA-AIneutral
09/06/23 6:00 AMNasdaq : ICLR conferencesICON plc to Present at the Baird Global Healthcare ConferenceICON plc, a world-leading clinical research organisation powered by healthcare intelligence, today announced that Dr. Steve Cutler, CEO of ICON plc, will present at the Baird Global Healthcare Conference on Wednesday, September 13, 2023 at 10:15 am ET. With headquarters in Dublin, Ireland, ICON employed approximately 41,160 employees in 108 locations in 53...RHEA-AIneutral
07/26/23 4:20 PMNasdaq : ICLR ICON Shareholders Vote in Favour of All Resolutions at its Annual General MeetingICON plc, a world-leading healthcare intelligence and clinical research organisation, today announced that all resolutions at the Annual General Meeting of the Company held on July 25, 2023 were all duly passed by shareholders. These resolutions were set out in the Notice of the AGM sent to shareholders dated June 12, 2023 and are available on the ICON plc...RHEA-AIneutral
07/26/23 4:15 PMNasdaq : ICLR earningsICON Reports Second Quarter 2023 ResultsWe now expect revenue in the range of $8,070- $8,210 million for the full-year 2023, representing growth of 4.3 to 6.1% on a year over year basis. Given our strong margin performance, as well as a more favorable tax position, we are revising our adjusted earnings per share* range to $12.63- $12.91, reflecting a year over year increase of 7.5 to 9.9%, an increase of$. 04 at...RHEA-AIneutral
07/13/23 7:15 AMNasdaq : ICLR First Half of 2023 Sees ICON Recognised for CRO Excellence, Alongside Industry Awards as an Employer of Choice and for Its Creative and Digital ServicesICON plc, a world-leading healthcare intelligence and clinical research organisation, has received positive recognition from leading business and industry organisations as a leading CRO of choice and a top-rated employer in the first half of 2023.. For its excellent performance in clinical research, ICON was named a recipient of the 2023 CRO Leadership...RHEA-AIvery positive
06/27/23 4:15 PMNasdaq : ICLR earningsICON plc Schedules Second Quarter 2023 Earnings Conference CallICON plc, a world-leading healthcare intelligence and clinical research organization, today announced that it will release its financial results for the second quarter 2023 after the market closes on Wednesday, July 26, 2023. The company will hold a conference call and webcast to discuss its financial results and performance on Thursday, July 27, 2023 at...RHEA-AIneutral
06/26/23 7:15 AMNasdaq : ICLR ICON Releases Latest Version of its Digital Platform, Providing Integrated Patient Services and Harmonised Data in One PlatformICON plc, a world-leading healthcare intelligence and clinical research organisation, today announced the latest release of its Digital Platform. The platform supports seamless integration of ICON patient, site and sponsor services with the delivery of harmonised data and can be customised for any study design, from traditional to fully decentralised,...RHEA-AIpositive
06/26/23 6:00 AMNasdaq : ICLR ICON plc Set to Join Russell 3000® IndexICON plc,, is set to join the broad-market Russell 3000 ® Index at the conclusion of the 2023 Russell indexes annual reconstitution, effective after the US market opens today, Monday, June 26.. Annual Russell indexes reconstitution captures the 4,000 largest US stocks as of April 28, ranking them by total market capitalization, including both the Russell 3000...RHEA-AIneutral